A916: rectum: adenocarcinoma
|
|
- Ginger Nash
- 6 years ago
- Views:
Transcription
1 General facts of colorectal cancer The colon has cecum, ascending, transverse, descending and sigmoid colon sections. Cancer can start in any of the r sections or in the rectum. The wall of each of these sections (and rectum) has several layers of tissues. Cancer starts in the inner layer and can grow through some or all of the other layers. Knowing a little about these layers is helpful because the stage (extent of spread) of a cancer depends to a great degree on which of these layers it affects. Cancer that starts in the different areas may cause different symptoms. Colon and rectum cancers probably develop slowly over a period of several years. We now know that most of these cancers begin as a polyp--a growth of tissue into the center of the colon or rectum. Polyps are also known as adenomas. Removing the polyp early may prevent it from becoming cancer. Over 95% of colon and rectal cancers are adenocarcinomas. These are cancers of the cells that line the inside of the colon and rectum. There are some other, more rare, types of tumors of the colon and rectum, but the facts given here refer only to adenocarcinomas. Colon and rectal cancer have many features in common and are often referred to together as colorectal cancer. Treatment Surgery is the main treatment for cancer of the large bowel. It may be used either alone, or in combination with radiotherapy and chemotherapy. The treatment will depend on the stage of the cancer (its position, size and whether it has spread). This is decided through the results of various tests and what is discovered during surgery. Sometimes doctor may advise other treatment before surgery. This is because the results of the tests and scans have already given the doctor a good idea of the stage of the cancer. Many people need to have surgery to remove the cancer. If the cancer is an early stage (Dukes A= Stage I), the aim of surgery is to completely remove the cancer, and this may cure it. In situations where the cancer is advanced and causing a blockage (obstruction) of the bowel, surgery may be used to remove this. This will not cure the cancer, but can relieve symptoms. Chemotherapy is often given after surgery to try to reduce the chances of the cancer coming back. It is also given when the cancer is advanced and has spread to other parts of the body. In some people, both radiotherapy and chemotherapy are combined and given together before surgery is carried out. This is called chemoradioation. Radiotherapy is usually only used to treat cancer of the rectum and can be given before or after surgery.
2 Primary tumor (T) Staging of colorectal cancer TX: Primary tumor cannot be assessed T0: No evidence of primary tumor Tis: Carcinoma in situ : intraepithelial or invasion of the lamina propria : Tumor invades submucosa T2: Tumor invades muscularis propria T3: Tumor invades through the muscularis propria into the subserosa, or into nonperitonealized pericolic or perirectal tissues T4: Tumor directly invades other organs or structures, and/or perforates visceral peritoneum Regional lymph nodes (N) NX: Regional nodes cannot be assessed N0: No regional lymph node metastasis : Metastasis in 1 to 3 regional lymph nodes N2: Metastasis in 4 or more regional lymph nodes Distant metastasis (M) MX: Distant metastasis cannot be assessed M0: No distant metastasis M1: Distant metastasis Stage Stage Stage Stage Stage 0 Tis, N0, M0 I, N0, M0 T2, N0, M0 IIA T3, N0, M0 IIB T4, N0, M0 IIIA,, M0 T2,, M0 IIIB T3,, M0 T4,, M0 IIIC Any T, N2, M0 IV Any T, Any N, M1 References 1. Colon and rectum. In: American Joint Committee on Cancer.: AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer, 2002, pp
3 Lot. No : Fig3. RT-PCR for GAP3DH / AGE: 56 Sex: Female Stage: T3M1 1.Rectum, segmental resection: Ulceroinfiltrating adenocarcinoma, moderately differentiated, extending into perirectal fat tissue with 1) occasional lympho vascular permeation and frequent perineural invasion. 2) resection margins, proximal and distal: Free of tumor. 3) resection margin, lateral: Extension of tumor. 4) regional lymph nodes, principal (1/1), perirectal (1/18) : (2/19): 5) metastatic adenocarcinoma in 2 out of 19 nodes with perinodal tumor extension. * Post operation: chemotheraphy (5FU,Levorin) * Comment: hypothyroidism
4 Lot. No : Skin Fig 2. Scanned images for H&E stained slides. Skin Fig3. RT-PCR for GAP3DH Sample : Serial 10 sections of Skin / AGE: 44 Sex: Female Stage: T2N0M0 1.Rectum, Mile's operation: Adenocarcinoma, well differentiated, fungating type 1) extension to proper muscle layer without invasion into perirectal fat and vaginal wall 2) marked peritumoral inflammatory infiltrate and fibrosis. 3) resection margins, proximal and distal: Free of tumor. 4) regional lymph node, principal (0/0), perirectal (0/26): Free of tumor.
5 Lot. No : / AGE: 69 Sex: Male Stage: T3N2M0 1.Rectum with perirectal soft tissue, Miles' operation: Ulcerofungating adenocarcinoma, moderately differentiated, 1) size: 4x3.8cm 2) infiltrating growth 3) penetration of muscle layer and extension to perirectal soft tissue 4) vascular and perineural invasion 5) intact proximal and distal(anus) resection margins but extension to lateral one 6) metastasis to 8 out of 41 perirectal lymph nodes (perirectal (8/32), principal (0/9)) 7) two tubular adenomas with low to focal high grade dysplasia the surrounding mucosa * Post operation: adjuvant chemotheraphy (5Fu, Leorin) * Comments: with hepatocellular carcinoma
6 Lot. No : / AGE: 72 Sex: Male Stage: T3N0M0 1.Rectum, low anterior resection: Adenocarcinoma, moderately differentiated, ulcerative type with 1) extension to the perirectal fat tissue. 2) resection margins, proximal, distal and lateral: Free of tumor. 3) lymph nodes, regional (0/16): Free of tumor. 2.Soft tissue, separately submitted as principal node: Free of tumor. * Comments: smoking 50 years
7 Lot. No : Fig3. RT-PCR for GAP3DH / AGE: 38 Sex: Male Stage: T3N2M0 1. Rectum, low anterior resection: Ulcerofungating adenocarcinoma moderately differentiated with 1) size: 6.2x5.2cm 2) infiltrative growth 3) extension to perirectal soft tissue but intact lateral resection margin 4) no vascular and perineural invasion 5) intact proximal and distal resection margins 6) metastasis to 5 out of 29 perirectal lymph nodes ( principal (0/9) and perirectal (5/20) ) MSI(Microsatellite instability) test Marker Name bat26 D5S346 bat25 D17S250 D2S123 Microsatellite No No No No No MSS instability Allelic uninformative uninformative No (0.79) No (1.28) Imbalance * Post operation: adjuvant chemotheraphy (5FU,Levorine)
8 Lot. No : Stomach Stomach Fig3. RT-PCR for GAP3DH Stomach / AGE: 73 Sex: Male Stage: T3N2M0 1.Rectum with perirectal soft tissue, Mile's operation: Ulceroinfiltrative adenocarcinoma, moderately differentiated, 1) size: 4.5x2.3cm. 2) infiltrative growth. 3) penetration of muscle layer and extension to perirectal fatty tissue. 4) perineural invasion but not vascular invasion. 5) intact proximal and distal resection margins. 6) metastasis to 5 out of 24 regional lymph nodes ( principal (0/1), perirectal(5/23) ). 7) surrounding mucosa showing tubular adenomas with low grade dysplasia. 2.Artery, clinically right internal iliac, segmental resection: Atherosclerosis. * Post operation: adjuvant chemotheraphy (5FU,Levorin)
9 A916: rectum: adenocacinoma Lot. No : / AGE: 69 Sex: Female Stage: T3M0 1.Rectum, segmental resection: Adenocarcinoma, moderately differentiated, ulceroinfiltrative type 1) extension to perirectal fat tissue without vascular permeation or perineural invasion. 2) resection margins, proximal and distal: Free of tumor. 3) esection margin, lateral: see note. 4) regional lymph nodes, principal (0/1), perirectal (1/17) : (1/18): Metastatic adenocarcinoma in one out of 18 nodes with perinodal tumor extension. Note: The tumor is very close to the lateral margin (about 0.6mm).
10 Lot. No : / AGE: 60 Sex: Male Stage: T3M0 1.Rectum, anterior resection: Adenocarcinoma, moderately differentiated, 1) ulcerofungating type. 2) size: 4.5x4.0cm 3) extension to perirectal fat tissue. 4) very close to lateral margin (within 0.5mm). 5) no lymphovascular permeation. 6) Tubular adenoma with low grade dysplasia. 7) regional lymph nodes, principal (0/2), peri-rectal (2/24):(2/26): Tumor metastasis in 2 out of 26 nodes. 8) separately submitted nodes with perinodal tumor extension: Tubular adenoma with low grade dysplasia. * Post operation : adjuvant chemotheraphy (5FU, Leucovorin). * Comments: alcohol
11 A916 rectum: adenocarcinoma Lot. No : N / AGE: 68 Sex: Female Stage: T3N0M1 1.Rectum, anterior resection: Adenocarcinoma, moderately differentiated, ulcerofungating type 1) extension to perirectal fat tissue and very close to serosa (<0.8mm). 2) resection margins, proximal and distal: Free of tumor. 3) regional lymph nodes, principal (0/10), perirectal (0/29):(0/39): Free of tumor.
12 Lot. No : / AGE: 56 Sex: Male Stage: T3N0M0 1.Rectum, Hartmann's operation: Adenocarcinoma, moderately differentiated, fungating type, 1) extension to the peirectal fat tissue and extensive lymphatic invasion. 2) resection margins, proximal and distal: Free of tumor. 3) lymph nodes, regional(0/11) and principal(0/0): Free of tumor metastasis in all 11 nodes. * Post operation: adjuvant chemotheraphy (5FU,Leucovorin)
13 A916: colon(rectum): adenocarcinoma Lot. No : for H&E stained slides / AGE: 62 Sex: Female Stage: T2N0M0 1.Total colorectum and terminal ileum, total colectomy: Fungating adenocarcinoma, moderately differentiated, arising from adenomatous polyp 1) size: 3.5x3cm. 2) expanding growth. 3) involving submucosal space and extending to proper muscle layer. 4) intact proximal and distal resection margins. 5) no metastasis to regional pericolic lymph nodes (0/72) and principal lymph node(0/0). 6) non-neoplastic mucosa showing multiple (about 30) adenomatous polyp i ncluding tubular and tubulovillous adenomas with low to high grade dysplasia. 2.Appendix, appendectomy, separately submitted: Free from tumor extension.
14 Lot. No : / AGE: 65 Sex: F Stage: T3N0M0 1.Rectum, segmental resection: Adenocarcinoma, well differentiated, ulceroinfiltrative, with 1) extension to the perirectal fat tissue 2) occasional lymphatic invasion. 3) resection margins, proximal and distal: Free of tumor. 4) lymph nodes, regional (0/21) and principal (0/2): Free of tumor metastasis in all 23 nodes. * Post operation :adjuvant chemotheraphy
Colorectal Cancer Structured Pathology Reporting Proforma DD MM YYYY
Colorectal Cancer Structured Pathology Reporting Proforma Mandatory questions (i.e. protocol standards) are in bold (e.g. S1.03). Family name Given name(s) Date of birth DD MM YYYY S1.02 Clinical details
More information11/21/13 CEA: 1.7 WNL
Case Scenario 1 A 70 year-old white male presented to his primary care physician with a recent history of rectal bleeding. He was referred for imaging and a colonoscopy and was found to have adenocarcinoma.
More information8. The polyp in the illustration can be described as (circle all that apply) a. Exophytic b. Pedunculated c. Sessile d. Frank
Quiz 1 Overview 1. Beginning with the cecum, which is the correct sequence of colon subsites? a. Cecum, ascending, splenic flexure, transverse, hepatic flexure, descending, sigmoid. b. Cecum, ascending,
More informationColon and Rectum. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6th edition
Colon and Rectum Protocol applies to all invasive carcinomas of the colon and rectum. Carcinoid tumors, lymphomas, sarcomas, and tumors of the vermiform appendix are excluded. Protocol revision date: January
More informationGastric Cancer Histopathology Reporting Proforma
Gastric Cancer Histopathology Reporting Proforma Mandatory questions (i.e. protocol standards) are in bold (e.g. S1.01). S1.01 Identification Family name Given name(s) Date of birth Sex Male Female Intersex/indeterminate
More informationLOINC. Clinical information. RCPA code. Record if different to report header Operating surgeon name and contact details. Absent.
Complete as narrative or use the structured format below 55752-0 17.02.28593 Clinical information 22027-7 17.02.30001 Record if different to report header Operating surgeon name and contact details 52101004
More informationCase presentation. Eran Zittan. MD Mount Sinai Hospital, Toronto, Canada. Emek Medical Center, Afula, Israel. March, 2016
Case presentation Eran Zittan. MD Mount Sinai Hospital, Toronto, Canada. Emek Medical Center, Afula, Israel. March, 2016 60 y/o man with long standing UC+PSC. Last 10 years on clinical and endoscopic remission.
More informationStaging Challenges in Lower GI Cancers. Disclosure of Relevant Financial Relationships. AJCC 8 th edition and CAP protocol updates
Staging Challenges in Lower GI Cancers Sanjay Kakar, MD University of California, San Francisco March 05, 2017 Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education
More informationTumours of the Oesophagus & Gastro-Oesophageal Junction Histopathology Reporting Proforma
Tumours of the Oesophagus & Gastro-Oesophageal Junction Histopathology Reporting Proforma Mandatory questions (i.e. protocol standards) are in bold (e.g. S1.01). S1.01 Identification Family name Given
More information2014/2015 FCDS Educational Webcast Series
2014/2015 FCDS Educational Webcast Series February 19, 2015 Steven Peace, CTR 2015 Update; Background, Anatomy, Risk Factors, Screening Guidelines, MPH Rules Review AJCC TNM 7 th ed, SS2000, CSv02.05 and
More informationAlison Douglass Gillian Lieberman, MD. November. Colon Cancer. Alison Douglass, Harvard Medical School Year III Gillian Lieberman, MD
November Colon Cancer Alison Douglass, Harvard Medical School Year III Our Patient Mr. K. is a 67 year old man with no prior medical problems other than hemorrhoids which have caused occasional rectal
More informationA218 : Esophagus cancer tissues. (formalin fixed)
(formalin fixed) For research use only Specifications: No. of cases: 40 Tissue type: Esophagus cancer tissues No. of spots: 2 spots from each cancer case (80 spots) 4 non-neoplastic spots (4 spots) Total
More information[A RESEARCH COORDINATOR S GUIDE]
2013 COLORECTAL SURGERY GROUP Dr. Carl J. Brown Dr. Ahmer A. Karimuddin Dr. P. Terry Phang Dr. Manoj J. Raval Authored by Jennifer Lee A cartoon about colonoscopies. 1 [A RESEARCH COORDINATOR S GUIDE]
More informationColon and Rectum 5/1/14
Collecting Cancer Data: Colon and Rectum 2013 2014 NAACCR Webinar Series May 1, 2014 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants
More informationA103(9)- Normal tissues, more than single spots
A103(9)- Normal tissues, more than single spots (formalin fixed) For research use only Specifications: No. of cases: 45 Tissue type: Normal tissues, more than single spots No. of spots: 2 spots from each
More informationThe Rodger C. Haggitt Memorial Lecture
The Rodger C. Haggitt Memorial Lecture I got an email on 4/22/14 from Hala El Zamaity inviting me to give this lecture and giving me this topic: The ever changing TNM classification and its implication
More informationCollaborative Stage for TNM 7 - Revised 06/30/2008 [ Schema ]
Collaborative Stage for TNM 7 - Revised 06/30/2008 [ Schema ] CS Tumor Size 000 No mass/tumor found 001-988 001-988 millimeters (code exact size in millimeters) 989 989 millimeters or larger 990 Microscopic
More informationNavigators Lead the Way
RN Navigators Their Role in patients with Cancers of the GI tract Navigators Lead the Way Nurse Navigator Defined Nurse Navigator A clinically trained individual responsible for the identification and
More informationSmall Intestine. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6 th edition
Small Intestine Protocol applies to all invasive carcinomas of the small intestine, including those with focal endocrine differentiation. Excludes carcinoid tumors, lymphomas, and stromal tumors (sarcomas).
More informationA215- Urinary bladder cancer tissues
A215- Urinary bladder cancer tissues (formalin fixed) For research use only Specifications: No. of cases: 45 Tissue type: Urinary bladder cancer tissues No. of spots: 2 spots from each cancer case (90
More informationOverview. Collecting Cancer Data: Colon 11/5/2009. Collecting Cancer Data: NAACCR Webinar Series 1. Agenda NAACCR WEBINAR SERIES
Collecting Cancer Data: Colon 11/5/2009 Collecting Cancer Data: Colon/Rectum/Appendix NAACCR 2009 2010 WEBINAR SERIES Agenda Overview Treatment MP/H Rules CSv2 2 Overview Colon/Rectum/Appendix 2009 2010
More informationRectal Cancer Cookbook Update. A. JOURET-MOURIN with the collaboration of A Hoorens,P Demetter, G De Hertogh,C Cuvelier and C Sempoux
Rectal Cancer Cookbook Update A. JOURET-MOURIN with the collaboration of A Hoorens,P Demetter, G De Hertogh,C Cuvelier and C Sempoux Prof Dr A Jouret-Mourin, Department of Pathology, UCL, St Luc, Brussels
More informationNeoplasms of the Colon and of the Rectum
Neoplasms of the Colon and of the Rectum 2 0 1 5-2 0 1 6 F C D S E D U C A T I O N A L W E B C A S T S E R I E S S T E V E N P E A C E, B S, C T R F E B R U A R Y 1 8, 2 0 1 6 2016 Focus o Anatomy o SS
More informationAJCC 7 th Edition Staging Disease Site Webinar Colorectum
AJCC 7 th Edition Staging Disease Site Webinar Colorectum Donna M. Gress, RHIT, CTR Validating science. Improving patient care. This presentation was supported by the Cooperative Agreement Number DP13-1310
More information7 th Edition Staging. AJCC 7 th Edition Staging. Disease Site Webinar. Colorectum. Overview. This webinar is sponsored by
AJCC 7 th Edition Staging Colorectum Donna M. Gress, RHIT, CTR Validating science. Improving patient care. This presentation was supported by the Cooperative Agreement Number DP13-1310 from The Centers
More informationColorectal adenocarcinoma leading cancer in developed countries In US, annual deaths due to colorectal adenocarcinoma 57,000.
Colonic Neoplasia Remotti Colorectal adenocarcinoma leading cancer in developed countries In US, annual incidence of colorectal adenocarcinoma 150,000. In US, annual deaths due to colorectal adenocarcinoma
More informationOutline. Colon and Rectal Cancers. Overview. Overview. Anatomic Distribution. Incidence and Mortality 12/12/2013
Colon and Rectal Cancers FCDS 2013-2014 Educational Webcast Series December 12, 2013 Mayra Espino, BA, RHIT, CTR Steven Peace, BS, CTR FCDS QC Staff 1 Outline Overview Incidence/Mortality/Survival Risk
More informationJoseph Misdraji, M.D. GI pathology Unit Massachusetts General Hospital
Joseph Misdraji, M.D. GI pathology Unit Massachusetts General Hospital jmisdraji@partners.org Low-grade appendiceal mucinous neoplasm (LAMN) High-grade appendiceal mucinous neoplasm (HAMN) Adenocarcinoma
More informationColon and Rectal Cancers. Outline. Overview 12/12/2013. FCDS Educational Webcast Series December 12, 2013
Colon and Rectal Cancers FCDS 2013-2014 Educational Webcast Series December 12, 2013 Mayra Espino, BA, RHIT, CTR Steven Peace, BS, CTR FCDS QC Staff 1 Outline Overview Incidence/Mortality/Survival Risk
More informationADVANCES IN COLORECTAL CANCERS IS THERE HOPE? Dr Lim Hwee Yong Medical Oncologist
ADVANCES IN COLORECTAL CANCERS IS THERE HOPE? Dr Lim Hwee Yong Medical Oncologist limhweeyong@live.com CRC: Epidemiology in 2012 Third most common cancer diagnosis in US [1] Estimated 143,460 new cases
More informationSEER EOD AND SUMMARY STAGE ABSTRACTORS TRAINING
SEER EOD AND SUMMARY STAGE ABSTRACTORS TRAINING OVERVIEW What is SEER EOD Ambiguous Terminology General Guidelines EOD Primary Tumor EOD Regional Nodes EOD Mets Site Specific Data Items (SSDI) SEER Summary
More informationColon and Rectum. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6th edition
Colon and Rectum Protocol applies to all invasive carcinomas of the colon and rectum. Carcinoid tumors, lymphomas, sarcomas, and tumors of the vermiform appendix are excluded. Protocol revision date: January
More informationSeventh Edition Staging 2017 Colorectum. Overview. This webinar is sponsored by. the Centers for Disease Control and Prevention.
Seventh Edition Staging 2017 Colorectum Donna M. Gress, RHIT, CTR Validating science. Improving patient care. No materials in this presentation may be repurposed in print or online without the express
More informationImaging in gastric cancer
Imaging in gastric cancer Gastric cancer remains a deadly disease because of late diagnosis. Adenocarcinoma represents 90% of malignant tumors. Diagnosis is based on endoscopic examination with biopsies.
More informationIMAGING GUIDELINES - COLORECTAL CANCER
IMAGING GUIDELINES - COLORECTAL CANCER DIAGNOSIS The majority of colorectal cancers are diagnosed on colonoscopy, with some being diagnosed on Ba enema, ultrasound or CT. STAGING CT chest, abdomen and
More informationCOLORECTAL CANCER FAISALGHANISIDDIQUI MBBS; FCPS; PGDIP-BIOETHICS; MCPS-HPE
COLORECTAL CANCER FAISALGHANISIDDIQUI MBBS; FCPS; PGDIP-BIOETHICS; MCPS-HPE PROFESSOR OF SURGERY & DIRECTOR, PROFESSIONAL DEVELOPMENT CENTRE J I N N A H S I N D H M E D I C A L U N I V E R S I T Y faisal.siddiqui@jsmu.edu.pk
More informationImaging Evaluation of Polyps. CT Colonography: Sessile Adenoma. Polyps, DALMs & Megacolon Objectives
Polyps, DALMs & Megacolon: Pathology and Imaging of the Colon and Rectum Angela D. Levy and Leslie H. Sobin Washington, DC Drs. Levy and Sobin have indicated that they have no relationships which, in the
More informationCarcinoma of the Renal Pelvis and Ureter Histopathology
Carcinoma of the Renal Pelvis and Ureter Histopathology Reporting Proforma (NEPHROURETERECTOMY AND URETERECTOMY) Includes the International Collaboration on Cancer reporting dataset denoted by * Family
More informationHandling & Grossing of Colo-rectal Specimens for Tumours. for Medical Officers in Pathology
Handling & Grossing of Colo-rectal Specimens for Tumours for Medical Officers in Pathology Dr Gayana Mahendra Department of Pathology Faculty of Medicine University of Kelaniya Your Role in handling colorectal
More informationNeoplastic Colon Polyps. Joyce Au SUNY Downstate Grand Rounds, October 18, 2012
Neoplastic Colon Polyps Joyce Au SUNY Downstate Grand Rounds, October 18, 2012 CASE 55M with Hepatitis C, COPD (FEV1=45%), s/p vasectomy, knee surgery Meds: albuterol, flunisolide, mometasone, tiotropium
More informationQuiz. b. 4 High grade c. 9 Unknown
Quiz 1. 10/11/12 CT scan abdomen/pelvis: Metastatic liver disease with probable primary colon malignancy. 10/17/12 Colonoscopy with polypectomy: Adenocarcinoma of sigmoid colon measuring at least 6 mm
More informationUpdate on staging colorectal carcinoma, the 8 th edition AJCC. General overview of staging. When is staging required? 11/1/2017
Update on staging colorectal carcinoma, the 8 th edition AJCC Dale C. Snover, MD November 3, 2017 General overview of staging Reason for uniform staging Requirements to use AJCC manual and/or CAP protocols
More informationProtocol for the Examination of Specimens From Patients With Primary Carcinoma of the Colon and Rectum
Protocol for the Examination of Specimens From Patients With Primary Carcinoma of the Colon and Rectum Well-differentiated neuroendocrine neoplasms (carcinoid tumors) are not included. Based on AJCC/UICC
More informationSmall Intestine Cancer Early Detection, Diagnosis, and Staging
Small Intestine Cancer Early Detection, Diagnosis, and Staging Detection and Diagnosis Catching cancer early often allows for more treatment options. Some early cancers may have signs and symptoms that
More informationColorectal Pathway Board (Clinical Subgroup): Imaging Guidelines September 2015
Colorectal Pathway Board (Clinical Subgroup): Imaging Guidelines September 2015 1 Contents Page No. 1. Objective 3 2. Imaging Techniques 3 3. Staging of Colorectal Cancer 5 4. Radiological Reporting 6
More informationAJCC Cancer Staging 8 th Edition
AJCC Cancer Staging 8 th Edition Colon and Rectal Cancer Staging Update Webinar George J Chang, MD, MS Deputy Chair, Department of Surgical Oncology Chief, Colon and Rectal Surgery Professor of Surgical
More information(formalin fixed) 6 non-neoplastic spots (6 spots) Corresponding normal tissues with cancers: Yes Diameter: 1. 0 mm
CBA729-Test slide, Head and neck cancer tissues (formalin fixed) For research use only Specifications: No. of cases: 6 Tissue type: Test slide, Head and neck cancer tissues No. of spots: 6 spots from each
More informationReferences. GI Biopsies. What Should Pathologists Assistants Know About Gastrointestinal Histopathology? James M Crawford, MD, PhD
What Should Pathologists Assistants Know About Gastrointestinal Histopathology? James M Crawford, MD, PhD jcrawford1@nshs.edu Executive Director and Senior Vice President for Laboratory Services North
More informationGreater Manchester & Cheshire Guidelines for Pathology Reporting for Oesophageal and Gastric Malignancy
Greater Manchester & Cheshire Guidelines for Pathology Reporting for Oesophageal and Gastric Malignancy Authors: Dr Gordon Armstrong, Dr Sue Pritchard 1. General Comments 1.1 Cancer reporting: Biopsies
More informationCarcinoma of the Urinary Bladder Histopathology
Carcinoma of the Urinary Bladder Histopathology Reporting Proforma (Radical & Partial Cystectomy, Cystoprostatectomy) Includes the International Collaboration on Cancer reporting dataset denoted by * Family
More informationGastric Cancer in a Young Postpartum Female. Kings County Hospital Center SUNY Downstate Case Conference May 24, 2012
Gastric Cancer in a Young Postpartum Female Kings County Hospital Center SUNY Downstate Case Conference May 24, 2012 Case HPI: 31 yo F, G5P3, 3 weeks s/p C-section, with gastric outlet obstruction. Pt
More informationA superficial radiotherapy B single pass curettage C excision with 2 mm margins D excision with 5 mm margins E Mohs micrographic surgery.
1- A 63-year-old woman presents with a non-healing lesion on her right temple that has been present for over two years. On examination there is a 6 mm well defined lesion with central ulceration, telangiectasia
More informationPreoperative Data Colorectal Cancer Database
Preoperative Data Please place patient label here Patient Information Patient s Last Name First Middle Initial UR MH MP Birth Date Sex Post Code / / M F ECOG (see codes below) Date of Diagnosis Consultant
More informationA301 VI- Various cancer tissues with corresponding normal tissues
A301 VI- Various cancer tissues with (formalin fixed) For research use only Specifications: No. of cases: 28 Tissue type: Various cancer tissues with No. of spots: 2 spots from each cancer case (56 spots)
More informationCOLON CANCER CARE GUIDELINES NON-METASTATIC DISEASE
COLON CANCER CARE GUIDELINES NON-METASTATIC DISEASE Guideline Authors: Todd S. Crocenzi, M.D.; Mark Whiteford, M.D.; Matthew Solhjem, M.D.; Carlo Bifulco, M.D.; Melissa Li, M.D.; Christopher Cai, M.D.;
More informationEarly colorectal cancer Quality and rules for a good pathology report Histoprognostic factors
Early colorectal cancer Quality and rules for a good pathology report Histoprognostic factors Frédéric Bibeau, MD, PhD Pathology department Biopathology unit Institut du Cancer de Montpellier France Quality
More informationDefinition of Synoptic Reporting
Definition of Synoptic Reporting The CAP has developed this list of specific features that define synoptic reporting formatting: 1. All required cancer data from an applicable cancer protocol that are
More informationPatologia sistematica V Gastroenterologia Prof. Stefano Fiorucci. Colon polyps. Colorectal cancer
Patologia sistematica V Gastroenterologia Prof. Stefano Fiorucci Colon polyps Colorectal cancer Harrison s Principles of Internal Medicine 18 Ed. 2012 Colorectal cancer 70% Colorectal cancer CRC and colon
More informationLocally Advanced Colon Cancer. Feiran Lou MD. MS. Richmond University Medical Center Department of Surgery
Locally Advanced Colon Cancer Feiran Lou MD. MS. Richmond University Medical Center Department of Surgery Case 34 yo man presented with severe RLQ abdominal pain X 24 hrs. No nausea/vomiting/fever. + flatus.
More informationGastric (Stomach) Cancer
Gastric (Stomach) Cancer Gastric cancer is a disease in which malignant (cancer) cells form in the lining of the stomach. The stomach is a J-shaped organ in the upper abdomen. It is part of the digestive
More informationCase Scenario 1. The patient has now completed his neoadjuvant chemoradiation and has been cleared for surgery.
Case Scenario 1 July 10, 2010 A 67-year-old male with squamous cell carcinoma of the mid thoracic esophagus presents for surgical resection. The patient has completed preoperative chemoradiation. This
More information2018 Updates for Neoplasms of the Appendix, Colon, Rectum and GI NETs
2018 Updates for Neoplasms of the Appendix, Colon, Rectum and GI NETs 1 2018-2019 FCDS WEBCAST SERIES 10/18/2018 STEVEN PEACE, CTR CDC & Florida DOH Attribution 2 Funding for this conference was made possible
More informationProtocol for the Examination of Specimens from Patients with Primary Carcinoma of the Colon and Rectum
Protocol for the Examination of Specimens from Patients with Primary Carcinoma of the Colon and Rectum Well-differentiated neuroendocrine neoplasms (carcinoid tumors) are not included. This modified NB
More informationProtocol for the Examination of Specimens From Patients With Primary Carcinoma of the Colon and Rectum
Protocol for the Examination of Specimens From Patients With Primary Carcinoma of the Colon and Rectum Well-differentiated neuroendocrine neoplasms (carcinoid tumors) are not included. Based on AJCC/UICC
More informationGastric Cancer Staging AJCC eighth edition. Duncan McLeod Westmead Hospital, NSW
Gastric Cancer Staging AJCC eighth edition Duncan McLeod Westmead Hospital, NSW Summary of changes New clinical stage prognostic groups, ctnm Postneoadjuvant therapy pathologic stage groupings, yptnm -
More informationQuiz Adenocarcinoma of the distal stomach has been increasing in the last 20 years. a. True b. False
Quiz 1 1. Which of the following are risk factors for esophagus cancer. a. Obesity b. Gastroesophageal reflux c. Smoking and Alcohol d. All of the above 2. Adenocarcinoma of the distal stomach has been
More informationClinical Colon Cancer Abby Siegel MD COLON CANCER. 1. Epidemiology 2. Risk factors 3. Manifestations 4. Treatment
Clinical Colon Cancer 2008 Abby Siegel MD COLON CANCER 1. Epidemiology 2. Risk factors 3. Manifestations 4. Treatment 1 1. EPIDEMIOLOGY - Colorectal cancer is the third most common cancer in the United
More informationWendy L Frankel. Chair and Distinguished Professor
1 Wendy L Frankel Chair and Distinguished Professor Case 1 59 y/o woman Abdominal pain No personal or family history of cancer History of colon polyps Colonoscopy Polypoid rectosigmoid mass Biopsy 3 4
More informationUnderstanding Your Pathology Report
Understanding Your Pathology Report Because every person s breast cancer is unique, it s important to understand the underlying biology of your tumor to personalize your treatment plan. Your physicians
More informationLUNG STAGING FORM LATERALITY: LEFT RIGHT BILATERAL
LUNG STAGING FORM LATERALITY: LEFT RIGHT BILATERAL ( ) Tx Primary tumor cannot be assessed, or tumor proven by the presence of malignant cells in sputum or bronchial washings but not visualized by imaging
More informationcolorectal cancer Colorectal cancer hereditary sporadic Familial 1/12/2018
colorectal cancer Adenocarcinoma of the colon and rectum is the third most common site of new cancer cases and deaths in men (following prostate and lung or bronchus cancer) and women (following breast
More informationPhysician s Cognitive and Communication Failures Result in Cancer Treatment Delay
1 Physician s Cognitive and Communication Failures Result in Cancer Treatment Delay Abstract: The estate of a 60 year old male alleged negligence against a gastroenterologist in failing to properly evaluate
More informationDiagnostic Difficulties Encountered Among Colorectal Polyps
Diagnostic Difficulties Encountered Among Colorectal Polyps Rhonda K. Yantiss, M.D. Professor of Pathology and Laboratory Medicine Department of Pathology and Laboratory Medicine Weill Cornell Medical
More informationA220: Larynx cancer tissues. (formalin fixed)
A220: Larynx cancer tissues (formalin fixed) For research use only Specifications: No. of cases: 45 Tissue type: Larynx cancer tissues No. of spots: 2 spots from each cancer case (90 spots) 4 non-neoplastic
More informationGuide to Colorectal Cancer
Guide to Colorectal Cancer Comprehensive, oncologist-approved cancer information from the American Society of Clinical Oncology (ASCO) www.cancer.net Made available through: ABOUT ASCO The American Society
More informationUICC TNM 8 th Edition Errata
UICC TNM 8 th Edition Errata ions are in italics Page 28 Oropharynx p16 positive Pathological Stage II,T2 N2 M0 T3 N0,N1 M0 Stage II,T2 N2 M0 T3,T4 N0,N1 M0 Page 61 Oesophagus Adenocarcinoma Pathological
More informationColon Cancer Prediction based on Artificial Neural Network
Global Journal of Computer Science and Technology Interdisciplinary Volume 13 Issue 3 Version 1.0 Year 2013 Type: Double Blind Peer Reviewed International Research Journal Publisher: Global Journals Inc.
More informationLarge Colorectal Adenomas An Approach to Pathologic Evaluation
Anatomic Pathology / LARGE COLORECTAL ADENOMAS AND PATHOLOGIC EVALUATION Large Colorectal Adenomas An Approach to Pathologic Evaluation Elizabeth D. Euscher, MD, 1 Theodore H. Niemann, MD, 1 Joel G. Lucas,
More informationFCDS March 2002 MONTHLY MEMO
.. FCDS March 2002 MONTHLY MEMO National Cancer Registrars Week: April 8-12, 2002 On behalf of the Florida Cancer Data System (FCDS) we would like to take this opportunity to sincerely thank all of the
More informationColon and Rectal Cancer. Treatment Guidelines for Patients
Colon and Rectal Cancer Treatment Guidelines for Patients Version IV/ February 2005 Colon and Rectal Cancer Treatment Guidelines for Patients Version IV/ February 2005 The mutual goal of the National
More informationCase Presentation, Discussion and Sharing of Information on Unresectable Colon Cancer
Case Presentation, Discussion and Sharing of Information on Unresectable Colon Cancer Jeffy G. Guerra, M.D. Level IV Surgery Resident OMMC-Surgery 041707 General Data 63 M Pandacan, Manila Chief Complaint
More informationColon and Rectum (Sarcomas, lymphomas, and carcinoid tumors of the large intestine are not included)
1 4 Colon and Rectum (Sarcomas, lymphomas, and carcinoid tumors of the large intestine are not included) 14 At-A-Glance SUMMARY OF CHANGES In the sixth edition, Stage II was subdivided into IIA and IIB
More informationRitu Nayar, MD Professor and Vice Chair of Pathology Northwestern University, Feinberg School of Medicine Chicago, IL
Ritu Nayar, MD Professor and Vice Chair of Pathology Northwestern University, Feinberg School of Medicine Chicago, IL email: r-nayar@northwestern.edu Nothing to disclose College of American Pathologists
More informationmalignant polyp Daily Challenges in Digestive Endoscopy for Endoscopists and Endoscopy Nurses BSGIE Annual Meeting 18/09/2014 Mechelen
Plan Incidental finding of a malignant polyp 1. What is a polyp malignant? 2. Role of the pathologist and the endoscopist 3. Quantitative and qualitative risk assessment 4. How to decide what to do? Hubert
More informationCervical cancer presentation
Carcinoma of the cervix: Carcinoma of the cervix is the second commonest cancer among women worldwide, with only breast cancer occurring more commonly. Worldwide, cervical cancer accounts for about 500,000
More information46. Merkel Cell Carcinoma
1 Terms of Use The cancer staging form is a specific document in the patient record; it is not a substitute for documentation of history, physical examination, and staging evaluation, or for documenting
More informationUICC TNM 8 th Edition Errata
UICC TNM 8 th Edition Errata ions are in italics Head and Neck Tumours Pages 20, p27, p34, p38, p41, and p49 ly pn2a Metastasis in a single ipsilateral lymph node, less than 3cm in greatest dimension with
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Kaminski MF, Regula J, Kraszewska E, et al. Quality indicators
More informationPatient. Male 76 year old C.C: abdominal pain
Patient Male 76 year old C.C: abdominal pain Bowel stool retention Suspected pulmonary TB at right upper lung Infiltration in right lower lung Pleural thickening at the Right chest Localized dilated small
More informationCase Scenario year-old white male presented to personal physician with dyspepsia with reflux.
Case Scenario 1 57-year-old white male presented to personal physician with dyspepsia with reflux. 7/12 EGD: In the gastroesophageal junction we found an exophytic tumor. The tumor occupies approximately
More informationIncidence and Multiplicities of Adenomatous Polyps in TNM Stage I Colorectal Cancer in Korea
Original Article Journal of the Korean Society of J Korean Soc Coloproctol 2012;28(4):213-218 http://dx.doi.org/10.3393/jksc.2012.28.4.213 pissn 2093-7822 eissn 2093-7830 Incidence and Multiplicities of
More informationProposed All Wales Vulval Cancer Guidelines. Dr Amanda Tristram
Proposed All Wales Vulval Cancer Guidelines Dr Amanda Tristram Previous FIGO staging FIGO Stage Features TNM Ia Lesion confined to vulva with
More informationProtocol for the Examination of Specimens from Patients with Primary Carcinomas of the Colon and Rectum
Protocol for the Examination of Specimens from Patients with Primary Carcinomas of the Colon and Rectum Well differentiated neuroendocrine neoplasms (carcinoid tumors) are not included. Based on AJCC/UICC
More informationColon, Rectum, and Appendix. Presentation Outline. Overview Tumor Characteristics
Colon, Rectum, and Appendix 2011 Reporting Requirements and CSv02.03.02 NCCN/ASCO Treatment Guidelines by Stage FCDS 2011 Educational Webcast Series September 15, 2011 Steven Peace, CTR Presentation Outline
More informationColon, Rectum, and Appendix
Colon, Rectum, and Appendix 2011 Reporting Requirements and CSv02.03.02 NCCN/ASCO Treatment Guidelines by Stage FCDS 2011 Educational Webcast Series September 15, 2011 Steven Peace, CTR Presentation Outline
More informationStaging of rectal cancer on MRI: What the surgeons want to know.
Staging of rectal cancer on MRI: What the surgeons want to know. Poster No.: C-1108 Congress: ECR 2014 Type: Educational Exhibit Authors: G. Ayub, R. Chittal, A. Lowe, A. S. Punekar ; Leeds/, 1 2 1 2 2
More informationDisclosure. Acknowledgement. What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Rectal cancer imaging. None
What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Zhen Jane Wang, MD Assistant Professor in Residence UC SF Department of Radiology Disclosure None Acknowledgement Hueylan Chern, MD, Department
More informationMolly Boyd, MD Glenn Mills, MD Syed Jafri, MD 1/1/2010
LSU HEALTH SCIENCES CENTER NSCLC Guidelines Feist-Weiller Cancer Center Molly Boyd, MD Glenn Mills, MD Syed Jafri, MD 1/1/2010 Initial Evaluation/Intervention: 1. Pathology Review 2. History and Physical
More information